progression
Showing 26 - 50 of >10,000
Silent Progression Activity Monitoring - SPAM Study
Not yet recruiting
- Multiple Sclerosis
- NO INTERVENTION
-
Nice, FranceCHU de Nice
Dec 5, 2022
Proteomics and Genomics Combined With CT to Predict CVD
Recruiting
- Coronary Artery Disease Progression
-
Amsterdam, NetherlandsAmsterdam UMC, location AMC
Mar 23, 2023
Chronic Kidney Diseases, Cardiovascular Diseases, Hypertension Trial (Fruits and vegetables (F+V), NaHCO3 Tablets, Usual Care)
Completed
- Chronic Kidney Diseases
- +2 more
- Fruits and vegetables (F+V)
- +2 more
- (no location specified)
Sep 18, 2023
1 asPotential Biomarker for Colorectal Cancer Diagnosis and
Not yet recruiting
- Colorectal Cancer
- Tumor Endothelial Marker 1 ( TEM1 ) by ELISA kits
- (no location specified)
Mar 20, 2023
Benign Prostatic Hyperplasia Trial in Assiut (Self management)
Active, not recruiting
- Benign Prostatic Hyperplasia
- Self management
-
Assiut, EgyptFaculty of Nursing
Sep 21, 2023
Gastrointestinal Cancer Trial (Capecitabine, Sacituzumab govetican)
Not yet recruiting
- Gastrointestinal Cancer
- Capecitabine
- Sacituzumab govetican
- (no location specified)
Oct 2, 2023
Vitamin D in Periodontal and Cardiovascular Disease Progression
Completed
- Vitamin D Deficiency
- Evaluation of periodontal status
-
Messina, ItalyUniversity of Messina
Dec 7, 2022
Neuromelanin MRI: A Progression Marker in Early PD
Recruiting
- Parkinson Disease
- Progression, Disease
- MRI
-
Nottingham, United KingdomUniversity of Nottingham
Nov 18, 2022
Parkinson Disease Trial (Ambroxol Hydrochloride (420mg), Placebo)
Not yet recruiting
- Parkinson Disease
- Ambroxol Hydrochloride (420mg)
- Placebo
- (no location specified)
Mar 9, 2023
Macular Damage in Early Glaucoma and Progression
Recruiting
- Glaucoma
-
New York, New YorkCUIMC Harkness Eye Institute
Nov 4, 2022
Hepatocellular Carcinoma Trial in Seoul (Lenvatinib)
Recruiting
- Hepatocellular Carcinoma
-
Seoul, Korea, Republic ofAsan Medical Center
Nov 14, 2023
AKI - Acute Kidney Injury Trial in Alexandria (renal cell arrest and damage biomarkers assessment)
Not yet recruiting
- AKI - Acute Kidney Injury
- renal cell arrest and damage biomarkers assessment
-
Alexandria, EgyptFaculty of Medicine, Aexandria University
Sep 26, 2023
Myopia Trial in Singapore (Test myopia control lenses (DAL))
Not yet recruiting
- Myopia
- Test myopia control lenses (DAL)
-
Singapore, SingaporeEssilor R&D Centre Singapore
Apr 21, 2023
Sepsis, Acute Infection, Organ Failure Trial (Fisetin-dose 1, Fisetin-dose 2, Placebo)
Not yet recruiting
- Sepsis
- +2 more
- Fisetin-dose 1
- +2 more
- (no location specified)
Feb 24, 2023
Dentist's Role Trial in Cairo (SDF1, Diode Laser, Pit Fissure Sealant)
Completed
- Dentist's Role
- SDF1
- +2 more
-
Cairo, EgyptFaculty of Dentistry British University
Nov 5, 2023
Facioscapulohumeral Muscular Dystrophy Type 2 Trial in France, Italy, Spain (Validation of new COMs for FSHD2 patients)
Recruiting
- Facioscapulohumeral Muscular Dystrophy Type 2
- Validation of new COMs for FSHD2 patients
-
Nice, Alpes M, France
- +5 more
Oct 6, 2023
Radiotherapy Combined With EGFR-TKI for Stage III EGFR Mutant
Completed
- The Primary Study Metric is Progression-free Survival (PFS)
- (no location specified)
Jun 28, 2023
Impact of Non-Exudative Type 1 MNV on AMD Progression
Recruiting
- Age-Related Macular Degeneration
- Neovascularization, Choroidal
-
Salt Lake City, UtahUniversity of Utah
Nov 15, 2023
Parkinson Disease Trial (Improvised Active Music Therapy)
Not yet recruiting
- Parkinson Disease
- Improvised Active Music Therapy
- (no location specified)
Jul 24, 2023
Immune Function and the Progression to T1D
Recruiting
- Type 1 Diabetes
- blood draw
-
Gainesville, FloridaKieran McGrail
Jun 12, 2023
Pressure Ulcer Trial in Kayseri (topical pomegranate seed oil, Sesame oil)
Not yet recruiting
- Pressure Ulcer
- topical pomegranate seed oil
- Sesame oil
-
Kayseri, Turkey
- +1 more
Nov 29, 2023
Survival Analysis in Children and Adults Adrenocortical Cancer
Active, not recruiting
- Adrenocortical Carcinoma
-
Bethesda, MarylandNational Cancer Institute (NCI)
Jan 20, 2023
Myopia Trial in Yuexiu, Nankai (Novel spectacle lens, Single vision spectacle lens)
Not yet recruiting
- Myopia
- Novel spectacle lens
- Single vision spectacle lens
-
Yuexiu, Guangzhou, China
- +1 more
May 23, 2023
Prediction of Progression of Retinal Ischemia in Diabetes
Recruiting
- Diabetic Retinopathy
-
Coimbra, PortugalAIBILI-CEC (AIBILI- Clinical Trials Centre)
Dec 21, 2022
The Clinical Course and Factors for Progression of
Recruiting
- Dyspepsia
-
Xi'an, Shaanxi, ChinaAir Force Military Medical University, China
Apr 10, 2023